Oncology is the largest pharma market and among most competitive. Despite huge progress, large unmet medical needs remain. Increasingly...

Excellent presentations during 1st day of MedTetch Commercial Leaders Forum, with great speakers such as Stephen Laws, Hank Sczerba and...

As patient care evolves toward hybrid remote / in-person, Pharma and Medtech need to accelerate move to integrated omnichannel...

With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and...

In post-Covid, health professionals want more support and interactions from representatives, through a mix of virtual and in-person. This...

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies. For post-covid commercial restart, life science...

How can Pharma and MedTech boost sales teams in post-covid: Adjust sales and resource expectations around scenarios Re-work incentives...

The Covid-19 outbreak, with countless of cases and half a million deaths to date, has brought a massive impact to patients, families, and...

Shift to digital only and remote interactions was/is the only available option during the pandemic. I expect the new normal to be...

Launching in pandemic time requires bold moves, such as those taken by Esperion, Horizon, Eisai or Clarus: - remote interactions with...

Launching in post-Covid time requires creativity. For its new lip-filler, Galderma is providing digital materials for healthcare...

Hospital & Health system survey give key insights for Pharma and Medtech business re-start : - elective procedure volumes will not return...

Pharma and MedTech need to anticipate healthcare restart timing and steps, and adapt customer engagement accordingly. US Hospital...

In a challenging post-Covid time for Pharma and MedTech, assess customers needs to reallocate effort and prepare business re-start. Join...

Beyond launch events and face-to-face push, how should Pharma & MedTech launch products in a post-Covid world ? Novartis has recently...

Despite dramatic impact during Covid19 outbreak, Pharma and MedTech are expected to be relatively protected on the long run, particularly...

According to latest HCP and consumer surveys performed in 10 countries, Covid crisis has reduced patients visits by 45%, Rep-HCP...

Health professionals, patients, and sales reps have all become digital-fluent. What are the implications for your go-to-market and...

To shape the new normal, Pharma and Medtech companies need to push the boundaries on digital, patient-centered trial design, supply chain...

How will Covid-19 outbreak impact Pharma and MedTech sales? J&J forecast shared during the company’s first-quarter conference call give...